{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:10:10Z","timestamp":1794453010061,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,5,13]]},"DOI":"10.1038\/s41388-026-03737-5","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:32:12Z","timestamp":1775014332000},"page":"1544-1556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["LDHA-driven lactate metabolism promotes MDSC activation and immunosuppressive microenvironment in prostate cancer"],"prefix":"10.1038","volume":"45","author":[{"given":"Xiyi","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-1136","authenticated-orcid":false,"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zige","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1199-7152","authenticated-orcid":false,"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1074-281X","authenticated-orcid":false,"given":"Yize","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9462-7677","authenticated-orcid":false,"given":"Shouyong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-2760","authenticated-orcid":false,"given":"Bing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"3737_CR1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41585-018-0060-7","volume":"15","author":"NJ Sathianathen","year":"2018","unstructured":"Sathianathen NJ, Konety BR, Crook J, Saad F, Lawrentschuk N. Landmarks in prostate cancer. Nat Rev Urol. 2018;15:627\u201342. https:\/\/doi.org\/10.1038\/s41585-018-0060-7.","journal-title":"Nat Rev Urol"},{"key":"3737_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101199","volume":"4","author":"D Sridaran","year":"2023","unstructured":"Sridaran D, Bradshaw E, DeSelm C, Pachynski R, Mahajan K, Mahajan NP. Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach. Cell Rep Med. 2023;4:101199. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101199.","journal-title":"Cell Rep Med"},{"key":"3737_CR3","doi-asserted-by":"publisher","first-page":"47.","DOI":"10.1007\/s44178-024-00118-4","volume":"3","author":"B Dai","year":"2024","unstructured":"Dai B, Wang H, Shi B, Xing J, Zhu S, He Z, et al. CACA guidelines for holistic integrative management of prostate cancer. Holist Integ Oncol. 2024;3:47. https:\/\/doi.org\/10.1007\/s44178-024-00118-4.","journal-title":"Holist Integ Oncol"},{"key":"3737_CR4","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1158\/0008-5472.can-19-2948","volume":"80","author":"HR Cha","year":"2020","unstructured":"Cha HR, Lee JH, Ponnazhagan S. Revisiting immunotherapy: a focus on prostate cancer. Cancer Res. 2020;80:1615\u201323. https:\/\/doi.org\/10.1158\/0008-5472.can-19-2948.","journal-title":"Cancer Res"},{"key":"3737_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","volume":"606","author":"X Guan","year":"2022","unstructured":"Guan X, Polesso F, Wang C, Sehrawat A, Hawkins RM, Murray SE, et al. Androgen receptor activity in T cells limits checkpoint blockade efficacy. Nature. 2022;606:791\u20136. https:\/\/doi.org\/10.1038\/s41586-022-04522-6.","journal-title":"Nature"},{"key":"3737_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27349-7","volume":"12","author":"Y Deng","year":"2021","unstructured":"Deng Y, Xia X, Zhao Y, Zhao Z, Martinez C, Yin W, et al. Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Nat Commun. 2021;12:7041. https:\/\/doi.org\/10.1038\/s41467-021-27349-7.","journal-title":"Nat Commun"},{"key":"3737_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41586-023-06511-9","volume":"621","author":"C Wang","year":"2023","unstructured":"Wang C, Zheng X, Zhang J, Jiang X, Wang J, Li Y, et al. CD300ld on neutrophils is required for tumour-driven immune suppression. Nature. 2023;621:830\u20139. https:\/\/doi.org\/10.1038\/s41586-023-06511-9.","journal-title":"Nature"},{"key":"3737_CR8","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Najafi M, Mortezaee K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019;234:8509\u201321. https:\/\/doi.org\/10.1002\/jcp.27782.","journal-title":"J Cell Physiol"},{"key":"3737_CR9","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Tom\u00e1s, R & P\u00e9rez-Guill\u00e9n, I Lactate in the Tumor microenvironment: an essential molecule in cancer progression and treatment. Cancers. 2020;12 https:\/\/doi.org\/10.3390\/cancers12113244.","DOI":"10.3390\/cancers12113244"},{"key":"3737_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10:38 https:\/\/doi.org\/10.1038\/s41392-024-02082-x.","journal-title":"Signal Transduct Target Ther"},{"key":"3737_CR11","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.ccell.2023.05.015","volume":"41","author":"Y Qian","year":"2023","unstructured":"Qian Y, Galan-Cobo A, Guijarro I, Dang M, Molkentine D, Poteete A, et al. MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma. Cancer Cell. 2023;41:1363\u201380.e1367. https:\/\/doi.org\/10.1016\/j.ccell.2023.05.015.","journal-title":"Cancer Cell"},{"key":"3737_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110451","volume":"38","author":"JL Zhao","year":"2022","unstructured":"Zhao JL, Ye YC, Gao CC, Wang L, Ren KX, Jiang R, et al. Notch-mediated lactate metabolism regulates MDSC development through the Hes1\/MCT2\/c-Jun axis. Cell Rep. 2022;38:110451. https:\/\/doi.org\/10.1016\/j.celrep.2022.110451.","journal-title":"Cell Rep"},{"key":"3737_CR13","doi-asserted-by":"publisher","first-page":"20159","DOI":"10.1073\/pnas.1918986117","volume":"117","author":"N Li","year":"2020","unstructured":"Li N, Kang Y, Wang L, Huff S, Tang R, Hui H, et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci USA. 2020;117:20159\u201370. https:\/\/doi.org\/10.1073\/pnas.1918986117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3737_CR14","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888\u2013902. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031.","journal-title":"Cell"},{"key":"3737_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","journal-title":"Nat Methods"},{"key":"3737_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 2019;8:329\u201337. https:\/\/doi.org\/10.1016\/j.cels.2019.03.003.","journal-title":"Cell Syst"},{"key":"3737_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s40425-019-0674-1","volume":"7","author":"MC Apodaca","year":"2019","unstructured":"Apodaca MC, Wright AE, Riggins AM, Harris WP, Yeung RS, Yu L, et al. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells. J Immunother Cancer. 2019;7:230 https:\/\/doi.org\/10.1186\/s40425-019-0674-1.","journal-title":"J Immunother Cancer"},{"key":"3737_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00262-018-2170-8","volume":"68","author":"AM Bruger","year":"2019","unstructured":"Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, et al. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions. Cancer Immunol Immunother. 2019;68:631\u201344. https:\/\/doi.org\/10.1007\/s00262-018-2170-8.","journal-title":"Cancer Immunol Immunother"},{"key":"3737_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.Cd-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yang S, Ma J, Chen Z, Song G, Rao D, et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 2022;12:134\u201353. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0316.","journal-title":"Cancer Discov"},{"key":"3737_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","journal-title":"Innovation"},{"key":"3737_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32:381\u20136. https:\/\/doi.org\/10.1038\/nbt.2859.","journal-title":"Nat Biotechnol"},{"key":"3737_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-018-0698-6","volume":"563","author":"R Vento-Tormo","year":"2018","unstructured":"Vento-Tormo R, Efremova M, Botting R, Turco M, Vento-Tormo M, Meyer K, et al. Single-cell reconstruction of the early maternal-fetal interface in humans. Nature. 2018;563:347\u201353. https:\/\/doi.org\/10.1038\/s41586-018-0698-6.","journal-title":"Nature"},{"key":"3737_CR23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41592-022-01480-9","volume":"19","author":"B Li","year":"2022","unstructured":"Li B, Zhang W, Guo C, Xu H, Li L, Fang M, et al. Benchmarking spatial and single-cell transcriptomics integration methods for transcript distribution prediction and cell type deconvolution. Nat methods. 2022;19:662\u201370. https:\/\/doi.org\/10.1038\/s41592-022-01480-9.","journal-title":"Nat methods"},{"key":"3737_CR24","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1200\/jco.2004.05.158","volume":"22","author":"YP Yu","year":"2004","unstructured":"Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol. 2004;22:2790\u20139. https:\/\/doi.org\/10.1200\/jco.2004.05.158.","journal-title":"J Clin Oncol"},{"key":"3737_CR25","doi-asserted-by":"publisher","first-page":"e1006477","DOI":"10.1371\/journal.pgen.1006477","volume":"12","author":"Y Ding","year":"2016","unstructured":"Ding Y, Wu H, Warden C, Steele L, Liu X, Iterson MV, et al. Gene expression differences in prostate cancers between young and old men. PLoS Genet. 2016;12:e1006477 https:\/\/doi.org\/10.1371\/journal.pgen.1006477.","journal-title":"PLoS Genet"},{"key":"3737_CR26","doi-asserted-by":"publisher","unstructured":"Friedrich M, Wiedemann K, Reiche K, Puppel SH, Pfeifer G, Zipfel I, et al. The role of lncRNAs TAPIR-1 and -2 as diagnostic markers and potential therapeutic targets in prostate cancer. Cancers. 2020;12 https:\/\/doi.org\/10.3390\/cancers12051122.","DOI":"10.3390\/cancers12051122"},{"key":"3737_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.eururo.2020.06.001","volume":"78","author":"M Kreuz","year":"2020","unstructured":"Kreuz M, Otto DJ, Fuessel S, Blumert C, Bertram C, Bartsch S, et al. ProstaTrend-a multivariable prognostic rna expression score for aggressive prostate cancer. Eur Urol. 2020;78:452\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2020.06.001.","journal-title":"Eur Urol"},{"key":"3737_CR28","doi-asserted-by":"publisher","unstructured":"Firlej V, Soyeux P, Nourieh M, Huet E, Semprez F, Allory Y, et al. Overexpression of nucleolin and associated genes in prostate cancer. Int J Mol Sci 2022;23 https:\/\/doi.org\/10.3390\/ijms23094491.","DOI":"10.3390\/ijms23094491"},{"key":"3737_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ccell.2019.02.005","volume":"35","author":"A Sinha","year":"2019","unstructured":"Sinha A, Huang V, Livingstone J, Wang J, Fox N, Kurganovs N, et al. The proteogenomic landscape of curable prostate cancer. Cancer cell. 2019;35:414\u2013427. https:\/\/doi.org\/10.1016\/j.ccell.2019.02.005.","journal-title":"Cancer cell"},{"key":"3737_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/annonc\/mdx637","volume":"29","author":"S Jain","year":"2018","unstructured":"Jain S, Lyons C, Walker S, McQuaid S, Hynes S, Mitchell D, et al. Validation of a metastatic assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy. Ann Oncol Off J Eur Soc Med Oncol. 2018;29:215\u201322. https:\/\/doi.org\/10.1093\/annonc\/mdx637.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"3737_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust M, Liu C, Newman A, Alizadeh A. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359. https:\/\/doi.org\/10.1007\/978-1-4939-7493-1_12.","journal-title":"Methods Mol Biol"},{"key":"3737_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte A. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220. https:\/\/doi.org\/10.1186\/s13059-017-1349-1.","journal-title":"Genome Biol"},{"key":"3737_CR33","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u2013W14. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucleic Acids Res"},{"key":"3737_CR34","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"key":"3737_CR35","doi-asserted-by":"publisher","unstructured":"Antti K, Sini K, E, Heini ML, K, Maria K, et al. Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer. Nat Commun. 2024;15 https:\/\/doi.org\/10.1038\/s41467-024-54364-1.","DOI":"10.1038\/s41467-024-54364-1"},{"key":"3737_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41592-021-01358-2","volume":"19","author":"G Palla","year":"2022","unstructured":"Palla G, Spitzer H, Klein M, Fischer D, Schaar AC, Kuemmerle LB, et al. Squidpy: a scalable framework for spatial omics analysis. Nat Methods. 2022;19:171\u20138. https:\/\/doi.org\/10.1038\/s41592-021-01358-2.","journal-title":"Nat Methods"},{"key":"3737_CR37","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1038\/s41592-024-02463-8","volume":"21","author":"C Zhong","year":"2024","unstructured":"Zhong C, Ang KS, Chen J. Interpretable spatially aware dimension reduction of spatial transcriptomics with STAMP. Nat Methods. 2024;21:2072\u201383. https:\/\/doi.org\/10.1038\/s41592-024-02463-8.","journal-title":"Nat Methods"},{"key":"3737_CR38","doi-asserted-by":"publisher","unstructured":"Jovan, T, Ricardo Omar Ramirez, F, Attila, G, Denis, S & Julio, S-R Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. Genome Biol 2022;23 https:\/\/doi.org\/10.1186\/s13059-022-02663-5.","DOI":"10.1186\/s13059-022-02663-5"},{"key":"3737_CR39","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"P Hsu","year":"2013","unstructured":"Hsu P, Scott D, Weinstein J, Ran F, Konermann S, Agarwala V, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013;31:827\u201332. https:\/\/doi.org\/10.1038\/nbt.2647.","journal-title":"Nat Biotechnol"},{"key":"3737_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-020-01714-8","volume":"39","author":"Z Yang","year":"2020","unstructured":"Yang Z, Wang T, Wu D, Min Z, Tan J, Yu B. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer. J Exp Clin Cancer Res: CR. 2020;39:203 https:\/\/doi.org\/10.1186\/s13046-020-01714-8.","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"3737_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen S, Colombo M, Frey A, Greten T, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150. https:\/\/doi.org\/10.1038\/ncomms12150.","journal-title":"Nat Commun"},{"key":"3737_CR42","doi-asserted-by":"publisher","unstructured":"Kai L, Houhui S, Benxia Z, Xuejin O, Qizhi M, Yue C, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6 https:\/\/doi.org\/10.1038\/s41392-021-00670-9.","DOI":"10.1038\/s41392-021-00670-9"},{"key":"3737_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","volume":"19","author":"F Veglia","year":"2018","unstructured":"Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat Immunol. 2018;19:108\u201319. https:\/\/doi.org\/10.1038\/s41590-017-0022-x.","journal-title":"Nat Immunol"},{"key":"3737_CR44","doi-asserted-by":"publisher","unstructured":"Chen T, Liu J, Wang C, Wang Z, Zhou J, Lin J, et al. ALOX5 contributes to glioma progression by promoting 5-HETE-mediated immunosuppressive M2 polarization and PD-L1 expression of glioma-associated microglia\/macrophages. J Immunother Cancer. 2024;12 https:\/\/doi.org\/10.1136\/jitc-2024-009492.","DOI":"10.1136\/jitc-2024-009492"},{"key":"3737_CR45","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","volume":"211","author":"M Noman","year":"2014","unstructured":"Noman M, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, et al. PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014;211:781\u201390. https:\/\/doi.org\/10.1084\/jem.20131916.","journal-title":"J Exp Med"},{"key":"3737_CR46","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1200\/jco.2017.72.8030","volume":"35","author":"K Virgo","year":"2017","unstructured":"Virgo K, Basch E, Loblaw D, Oliver T, Rumble R, Carducci M, et al. Second-Line Hormonal Therapy For Men With Chemotherapy-na\u00efve, Castration-resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion. J Clin Oncol: Off J Am Soc Clin Oncol. 2017;35:1952\u201364. https:\/\/doi.org\/10.1200\/jco.2017.72.8030.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"3737_CR47","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1200\/jco.19.01638","volume":"38","author":"E Antonarakis","year":"2020","unstructured":"Antonarakis E, Piulats J, Gross-Goupil M, Goh J, Ojamaa K, Hoimes C, et al. Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study. J Clin Oncol Off J Am Soc Clin Oncol. 2020;38:395\u2013405. https:\/\/doi.org\/10.1200\/jco.19.01638.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3737_CR48","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/annonc\/mdy232","volume":"29","author":"A Hansen","year":"2018","unstructured":"Hansen A, Massard C, Ott P, Haas N, Lopez J, Ejadi S, et al. Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study. Ann Oncol: Off J Eur Soc Med Oncol. 2018;29:1807\u201313. https:\/\/doi.org\/10.1093\/annonc\/mdy232.","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol"},{"key":"3737_CR49","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.cmet.2021.07.007","volume":"33","author":"Q Wu","year":"2021","unstructured":"Wu Q, Liang X, Wang K, Lin J, Wang X, Wang P, et al. Intestinal hypoxia-inducible factor 2\u03b1 regulates lactate levels to shape the gut microbiome and alter thermogenesis. Cell Metab. 2021;33:1988\u20132003. https:\/\/doi.org\/10.1016\/j.cmet.2021.07.007.","journal-title":"Cell Metab"},{"key":"3737_CR50","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/cac2.12607","volume":"44","author":"J Cai","year":"2024","unstructured":"Cai J, Song L, Zhang F, Wu S, Zhu G, Zhang P, et al. Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma. Cancer Commun. 2024;44:1231\u201360. https:\/\/doi.org\/10.1002\/cac2.12607.","journal-title":"Cancer Commun"},{"key":"3737_CR51","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/gutjnl-2021-326070","volume":"72","author":"L Wang","year":"2023","unstructured":"Wang L, Liu Y, Dai Y, Tang X, Yin T, Wang C, et al. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment. Gut. 2023;72:958\u201371. https:\/\/doi.org\/10.1136\/gutjnl-2021-326070.","journal-title":"Gut"},{"key":"3737_CR52","doi-asserted-by":"publisher","unstructured":"Hu Z, Yu X, Ding R, Liu B, Gu C, Pan XW, et al. Glycolysis drives STING signaling to facilitate dendritic cell antitumor function. J Clin Invest. 2023;133 https:\/\/doi.org\/10.1172\/jci166031.","DOI":"10.1172\/jci166031"},{"key":"3737_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molimm.2022.12.015","volume":"154","author":"YT Zhang","year":"2023","unstructured":"Zhang YT, Xing ML, Fang HH, Li WD, Wu L, Chen ZP. Effects of lactate on metabolism and differentiation of CD4(+)T cells. Mol Immunol. 2023;154:96\u2013107. https:\/\/doi.org\/10.1016\/j.molimm.2022.12.015.","journal-title":"Mol Immunol"},{"key":"3737_CR54","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1016\/j.immuni.2024.08.008","volume":"57","author":"D Kim","year":"2024","unstructured":"Kim D, Kim G, Yu R, Lee J, Kim S, Gleason MR, et al. Inhibitory co-receptor Lag3 supports Foxp3(+) regulatory T cell function by restraining Myc-dependent metabolic programming. Immunity. 2024;57:2634\u201350.e2635. https:\/\/doi.org\/10.1016\/j.immuni.2024.08.008.","journal-title":"Immunity"},{"key":"3737_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102038","volume":"6","author":"K Yasukawa","year":"2025","unstructured":"Yasukawa K, Shimada S, Akiyama Y, Taniai T, Igarashi Y, Tsukihara S, et al. ACVR2A attenuation impacts lactate production and hyperglycolytic conditions attracting regulatory T cells in hepatocellular carcinoma. Cell Rep Med. 2025;6:102038. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102038.","journal-title":"Cell Rep Med"},{"key":"3737_CR56","doi-asserted-by":"publisher","first-page":"14667","DOI":"10.1021\/acsnano.3c02428","volume":"17","author":"J Yan","year":"2023","unstructured":"Yan J, Li W, Tian H, Li B, Yu X, Wang G, et al. Metal-phenolic nanomedicines regulate T-cell antitumor function for sono-metabolic cancer therapy. ACS Nano. 2023;17:14667\u201377. https:\/\/doi.org\/10.1021\/acsnano.3c02428.","journal-title":"ACS Nano"},{"key":"3737_CR57","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1158\/2159-8290.Cd-21-0764","volume":"11","author":"A Grover","year":"2021","unstructured":"Grover A, Sanseviero E, Timosenko E, Gabrilovich D. Myeloid-derived suppressor cells: a propitious road to clinic. Cancer Discov. 2021;11:2693\u2013706. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0764.","journal-title":"Cancer Discov"},{"key":"3737_CR58","doi-asserted-by":"publisher","unstructured":"Siska P, Beckermann K, Mason F, Andrejeva G, Greenplate A, Sendor A, et al. Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight, 2017;2. https:\/\/doi.org\/10.1172\/jci.insight.93411.","DOI":"10.1172\/jci.insight.93411"},{"key":"3737_CR59","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/1078-0432.Ccr-21-0299","volume":"28","author":"S Peng","year":"2022","unstructured":"Peng S, Hu P, Xiao YT, Lu W, Guo D, Hu S, et al. Single-cell analysis reveals EP4 as a target for restoring t-cell infiltration and sensitizing prostate cancer to immunotherapy. Clin Cancer Res. 2022;28:552\u201367. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-0299.","journal-title":"Clin Cancer Res"},{"key":"3737_CR60","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/eji.201546047","volume":"46","author":"A Werner","year":"2016","unstructured":"Werner A, Amann E, Schnitzius V, Habermeier A, Luckner-Minden C, Leuchtner N, et al. Induced arginine transport via cationic amino acid transporter-1 is necessary for human T-cell proliferation. Eur J Immunol. 2016;46:92\u2013103. https:\/\/doi.org\/10.1002\/eji.201546047.","journal-title":"Eur J Immunol"},{"key":"3737_CR61","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","volume":"28","author":"W Li","year":"2018","unstructured":"Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, et al. Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer. Cell Metab. 2018;28:87\u2013103.e106. https:\/\/doi.org\/10.1016\/j.cmet.2018.04.022.","journal-title":"Cell Metab"},{"key":"3737_CR62","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jconrel.2021.05.034","volume":"335","author":"C Xia","year":"2021","unstructured":"Xia C, Li M, Ran G, Wang X, Lu Z, Li T, et al. Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy. J Control Release. 2021;335:557\u201374. https:\/\/doi.org\/10.1016\/j.jconrel.2021.05.034.","journal-title":"J Control Release"},{"key":"3737_CR63","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer cell. 2022;40:201\u201318.e209. https:\/\/doi.org\/10.1016\/j.ccell.2022.01.001.","journal-title":"Cancer cell"},{"key":"3737_CR64","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591:645\u201351. https:\/\/doi.org\/10.1038\/s41586-020-03045-2.","journal-title":"Nature"},{"key":"3737_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn4508","volume":"10","author":"L Zhang","year":"2024","unstructured":"Zhang L, Xin C, Wang S, Zhuo S, Zhu J, Li Z, et al. Lactate transported by MCT1 plays an active role in promoting mitochondrial biogenesis and enhancing TCA flux in skeletal muscle. Sci Adv. 2024;10:eadn4508. https:\/\/doi.org\/10.1126\/sciadv.adn4508.","journal-title":"Sci Adv"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03737-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03737-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03737-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:02:36Z","timestamp":1776808956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03737-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":65,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026,5,13]]}},"alternative-id":["3737"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03737-5","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. This study was approved by the Ethics Committee of The Affiliated Cancer Hospital of Nanjing Medical University and Jiangnan University Medical Center. Written informed consent for publication was obtained from all the participants. Animal study was approved by the Institutional Animal Care and Use Committee of Nanjing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}